ANI Pharmaceuticals Correlations
| BSFA Stock | 56.00 1.50 2.75% |
The current 90-days correlation between ANI Pharmaceuticals and ecotel communication ag is -0.2 (i.e., Good diversification). The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
ANI Pharmaceuticals Correlation With Market
Good diversification
The correlation between ANI Pharmaceuticals and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
ANI |
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
Moving together with ANI Stock
Moving against ANI Stock
| 0.86 | MFZA | Mitsubishi UFJ Financial | PairCorr |
| 0.66 | S2P | SIMCERE PHARMAC GRP | PairCorr |
| 0.63 | AMZ | Amazon Inc | PairCorr |
| 0.55 | KBIA | KB Financial Group Earnings Call This Week | PairCorr |
| 0.42 | ECHA | Ecopetrol SA | PairCorr |
| 0.41 | 6GAA | Grupo Aval Acciones | PairCorr |
| 0.38 | H6D | Haleon PLC | PairCorr |
| 0.36 | 6GAA | Grupo Aval Acciones | PairCorr |
| 0.35 | ECHA | Ecopetrol SA | PairCorr |
| 0.34 | 2WGA | WOORI FIN GRP Earnings Call This Week | PairCorr |
| 0.32 | HYU | Hyundai Motor Earnings Call This Week | PairCorr |
| 0.31 | LP6 | LIVZON PHARMAC GRP | PairCorr |
| 0.31 | CJH | CanSino Biologics | PairCorr |
| 0.85 | UOF | URBAN OUTFITTERS | PairCorr |
| 0.82 | ROW | Texas Roadhouse | PairCorr |
| 0.74 | 54M | Motorcar Parts | PairCorr |
| 0.72 | BSD2 | Banco Santander SA | PairCorr |
| 0.72 | RHM | Rheinmetall AG | PairCorr |
| 0.71 | 2HRA | HR GmbH | PairCorr |
| 0.64 | MAQ | Marriott International | PairCorr |
| 0.64 | 63TA | Tencent Music Entert | PairCorr |
| 0.55 | 2HZ | Odyssean Investment Trust | PairCorr |
| 0.46 | MBG | Mercedes Benz Group | PairCorr |
| 0.46 | PTX | Palantir Technologies | PairCorr |
| 0.44 | E5T | Eurotech SpA | PairCorr |
| 0.44 | NU42 | Ribbon Communications Earnings Call This Week | PairCorr |
| 0.36 | 751 | Algonquin Power Utilities | PairCorr |
| 0.32 | CDZ0 | MHP HOTEL AG | PairCorr |
| 0.7 | E6Z | AECOM | PairCorr |
| 0.68 | INR | International Consolidated | PairCorr |
| 0.66 | 3LN | Live Nation Entertainment | PairCorr |
| 0.65 | ICA | Orica | PairCorr |
Related Correlations Analysis
| 0.53 | 0.2 | -0.32 | 0.34 | -0.09 | FOO | ||
| 0.53 | 0.56 | -0.01 | 0.4 | 0.47 | FOS | ||
| 0.2 | 0.56 | 0.05 | 0.41 | 0.71 | E4C | ||
| -0.32 | -0.01 | 0.05 | 0.43 | 0.48 | SRI | ||
| 0.34 | 0.4 | 0.41 | 0.43 | 0.49 | BW8 | ||
| -0.09 | 0.47 | 0.71 | 0.48 | 0.49 | R6N | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ANI Stock performing well and ANI Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ANI Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FOO | 1.45 | (0.01) | 0.00 | 0.49 | 0.00 | 3.17 | 12.04 | |||
| FOS | 1.39 | 0.22 | 0.05 | (9.69) | 1.28 | 3.23 | 11.53 | |||
| E4C | 0.97 | 0.15 | 0.01 | (13.85) | 1.17 | 2.38 | 11.95 | |||
| SRI | 2.40 | 0.22 | 0.02 | 1.31 | 2.73 | 4.76 | 19.11 | |||
| BW8 | 1.76 | 0.07 | (0.01) | 0.42 | 2.12 | 3.77 | 14.82 | |||
| R6N | 0.84 | 0.25 | 0.10 | (2.23) | 0.73 | 2.10 | 5.19 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in ANI Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
ANI Pharmaceuticals Corporate Management
Elected by the shareholders, the ANI Pharmaceuticals' board of directors comprises two types of representatives: ANI Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ANI. The board's role is to monitor ANI Pharmaceuticals' management team and ensure that shareholders' interests are well served. ANI Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ANI Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nikhil Lalwani | CEO Pres | Profile | |
| Meredith Cook | Gen VP | Profile | |
| Chad Gassert | Sr Strategy | Profile | |
| Elizabeth JD | Chief Disease | Profile | |
| James Marken | VP Devel | Profile | |
| Ori Gutwerg | VP Generics | Profile | |
| Stephen Carey | Sr CFO | Profile |